Get the Stockscreener App
1.11
0.89%
-0.01
After Hours:
1.12
0.01
+0.90%
Allarity Therapeutics Inc stock is traded at $1.11, with a volume of 66,857.
It is down -0.89% in the last 24 hours and down -2.63% over the past month.
Allarity Therapeutics Inc is a clinical-stage, precision medicine pharmaceutical company focused on developing novel anti-cancer therapeutics for patients with high unmet medical needs. The company is actively advancing the development of stenoparib, an orally available, small-molecule inhibitor for patients with advanced recurrent ovarian cancer. It is leveraging its proprietary Drug Response Predictor (DRP) technology to refine patient selection and improve clinical outcomes. The company operates as a single operating and reporting segment (developing a treatment for ovarian cancer) in two geographic areas: Denmark and the United States.
See More
Previous Close:
$1.12
Open:
$1.12
24h Volume:
66,857
Relative Volume:
0.30
Market Cap:
$17.82M
Revenue:
-
Net Income/Loss:
$-11.90M
P/E Ratio:
-0.00539
EPS:
-206.0125
Net Cash Flow:
$-12.75M
1W Performance:
+9.90%
1M Performance:
-2.63%
6M Performance:
+9.90%
1Y Performance:
+8.82%
1-Day Range:
$1.09
$1.16
1-Week Range:
$1.00
$1.18
52-Week Range:
$0.6138
$2.35
Allarity Therapeutics Inc Stock (ALLR) Company Profile
Name
Allarity Therapeutics Inc
Sector
Industry
Phone
401-426-4664
Address
24 SCHOOL ST., 2ND FLOOR, BOSTON
Compare ALLR with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ALLR
Allarity Therapeutics Inc
|
1.11 | 17.98M | 0 | -11.90M | -12.75M | -206.01 |
|
VRTX
Vertex Pharmaceuticals Inc
|
468.38 | 113.87B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
776.54 | 80.22B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
406.40 | 52.56B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
803.74 | 49.31B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
175.07 | 37.37B | 447.02M | -1.18B | -906.14M | -6.1812 |
Allarity Therapeutics Inc Stock (ALLR) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jul-28-25 | Initiated | Ascendiant Capital Markets | Buy |
Allarity Therapeutics Inc Stock (ALLR) Latest News
Allarity CEO says 2026 represents an ‘inflection point’ - Yahoo Finance
Cancer drug progress, cash runway updates in Allarity's year-end CEO letter - Stock Titan
Allarity Therapeutics, Inc. (NASDAQ:ALLR) Short Interest Down 21.9% in December - Defense World
Allarity Therapeutics Completes Additional Private Equity Financing - TipRanks
Is Allarity Therapeutics Inc. stock a buy before product launchesQuarterly Profit Summary & Reliable Breakout Forecasts - Улправда
How strong is Allarity Therapeutics Inc. stock balance sheet2025 Short Interest & Consistent Profit Trading Strategies - Улправда
How Allarity Therapeutics Inc. stock reacts to Fed rate cutsEarnings Overview Summary & Smart Investment Allocation Tips - Улправда
Is Allarity Therapeutics Inc. stock oversold or undervalued2025 Stock Rankings & Smart Allocation Stock Tips - Улправда
Hedge Fund Bets: How Allarity Therapeutics Inc. stock reacts to Fed rate cuts2025 Major Catalysts & AI Optimized Trading Strategy Guides - Улправда
Will Allarity Therapeutics Inc. stock maintain dividend yieldJuly 2025 Final Week & High Conviction Investment Ideas - DonanımHaber
Is Allarity Therapeutics Inc. stock a bargain at current levels2025 Sector Review & Verified Stock Trade Ideas - Улправда
Published on: 2025-12-19 05:31:28 - Улправда
Allarity Therapeutics Earnings Notes - Trefis
Allarity Therapeutics Secures $2.5M Through Private Placement - MSN
Ascendiant Capital Maintains Allarity Therapeutics (ALLR) Buy Recommendation - Nasdaq
ALLR: Ascendiant Capital Raises Price Target, Maintains Buy Rati - GuruFocus
Allarity Therapeutics updates CFO employment agreement with full-time terms By Investing.com - Investing.com Australia
Allarity Therapeutics Appoints Jeffrey Ervin as Full-Time CFO - TipRanks
Allarity Therapeutics updates CFO employment agreement with full-time terms - Investing.com
Will Allarity Therapeutics Inc. stock benefit from sector rotationTrade Exit Summary & Trade Opportunity Analysis - Newser
Will Allarity Therapeutics Inc. stock return to pre crisis levelsPortfolio Update Report & High Yield Stock Recommendations - Newser
Can Allarity Therapeutics Inc. stock continue upward trendJuly 2025 Rallies & Long Hold Capital Preservation Plans - Newser
Allarity Therapeutics Inc to offer up to $50 million in securities - marketscreener.com
How Allarity Therapeutics Inc. stock trades before earningsJuly 2025 Final Week & Free Real-Time Market Sentiment Alerts - BỘ NỘI VỤ
Published on: 2025-11-28 11:27:30 - moha.gov.vn
A new trading data show Allarity Therapeutics Inc (ALLR) is showing positive returns. - Setenews
Allarity Therapeutics Inc. (ALLR) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Metastatic Breast Cancer Pipeline Insights Report 2025: Uncovering Breakthrough Drug Candidates Driving Future Market Growth - The Globe and Mail
Allarity Therapeutics, Inc. (ALLR) Analyst Insights, Price Targets & Recommendations - Yahoo! Finance Canada
Is it too late to sell Allarity Therapeutics Inc.July 2025 Movers & High Yield Equity Trading Tips - newser.com
How Allarity Therapeutics Inc. stock performs in weak economyShare Buyback & Verified Momentum Stock Watchlist - newser.com
Will Allarity Therapeutics Inc. stock continue upward momentumJuly 2025 Decliners & Daily Stock Trend Reports - newser.com
Why Allarity Therapeutics Inc. stock appeals to analystsPortfolio Performance Report & Technical Pattern Based Signals - newser.com
Why retail investors pile into Allarity Therapeutics Inc. stockWeekly Loss Report & Verified Momentum Stock Ideas - newser.com
How Allarity Therapeutics Inc. stock reacts to oil pricesWeekly Trading Summary & High Accuracy Trade Alerts - newser.com
Applying big data sentiment scoring on Allarity Therapeutics Inc.July 2025 Summary & Fast Momentum Entry Tips - newser.com
Exit strategy if you’re trapped in Allarity Therapeutics Inc.Market Sentiment Summary & Daily Profit Focused Stock Screening - newser.com
Published on: 2025-11-19 00:17:48 - newser.com
Why hedge funds are buying Allarity Therapeutics Inc. stock2025 Big Picture & Safe Capital Growth Trade Ideas - newser.com
Real time breakdown of Allarity Therapeutics Inc. stock performanceMarket Trend Report & Weekly High Conviction Trade Ideas - newser.com
Is Allarity Therapeutics Inc. stock affected by interest rate hikesJuly 2025 Recap & Free Fast Gain Swing Trade Alerts - newser.com
Allarity Therapeutics Inc Stock Analysis and ForecastTake Profit Strategies & Smart Trading Plans for Every Investor Type - earlytimes.in
Allarity Therapeutics Inc Stock (ALLR) Financials Data
Revenue
Net Income
Cash Flow
EPS
2.52%
0.07%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):